Search Results
The default setting for search results displays All Content. If you prefer to see recent content only, please adjust the date filter.
Filter your results:
Types
Topics
22 Results Found
Study: Two-dose antibiotic may be as effective as IV therapy for serious staph infections
A study published by JAMA Aug. 13 found that a two-dose antibiotic treatment could be just as effective as traditional long-term IV therapy for treating serious Staphylococcus aureus bloodstream infections.
Infection Control and Prevention
Healthcare-Associated Infections (HAI) prevention and reduction are longstanding quality and patient safety priorities.
What Is a CLABSI and How to Prevent It
In this episode of the Advancing Health podcast series, Nishant Prasad, M.D., attending physician and program director of infectious diseases at NewYork-Presbyterian Queens, shares how they re-approached CLABSI prevention by deeply examining structure and process, and how their work got them to zero CLABSIs in the last year.
Hospital Onset Bacteremia
Sources of hospital onset bacteremia (HOB), its identification, how effectively HOB can be prevented, treated and considerations for quality metrics.
CDC report shows decreases in certain health care-associated infections in 2023
The Centers for Disease Control and Prevention Nov. 6 released its annual progress report on health care-associated infections, which showed continued decreases in hospitalizations last year.
CDC data show 10% drop in overdose deaths this year
Drug overdose deaths have dropped by 10% this year compared to last, according to data from the Centers for Disease Control and Prevention.
CDC investigating counterfeit, mishandled botulinum toxin injections
The Centers for Disease Control and Prevention and Food and Drug Administration are investigating adverse effects in 22 people in 11 states who received botulinum toxin injections that were counterfeit or administered in non-healthcare settings or by unlicensed or untrained individuals.
Henry Ford Health: Accelerating Efforts to Reduce CLABSI Rates Yields Promising Results
Henry Ford’s hematology-oncology unit has reduced the incidence of CLABSIs in its hematology-oncology unit by 75%, documenting only two cases between July 2020 and June 2021.
A Case Study in Reducing Central Line-Associated Bloodstream Infection (CLABSI) Rates
A Case Study in Reducing Central Line-Associated Bloodstream Infection (CLABSI) Rates